ADVERTISEMENT
Videos
Real-World Treatment Patterns and Outcomes Among Patients With Mantle Cell Lymphoma
07/21/2022
Mayur Narkhede, MD, Division of Hematology and Oncology, Department of Medicine, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, analyzed treatment patterns among patients with mantle cell lymphoma at different lines of therapy, focusing on Bruton tyrosine kinase inhibitor use. In this study, Dr Narkhede compared outcomes with known prognostic factors using an electronic health record database.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Current Issue
October 2024
Volume 10
Issue 5
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Subscribe
Journal of Clinical Pathways Newsletter
Advertisement
Advertisement
Advertisement
Recent Stories
Advertisement